Omeprazole-associated digoxin toxicity

Southern Medical Journal

Volumn 100, Issue 4, 2007, Pages 400-402

  Kiley, Cristin A ^a   Cragin, Douglas J ^a   Roth, Bernard J ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

Digoxin; Interaction; Omeprazole; Toxicity

Indexed keywords

DIGOXIN; DIGOXIN ANTIBODY F(AB) FRAGMENT; OMEPRAZOLE;

AGED; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG TOXICITY; FEMALE; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HUMAN;

AGED; ATRIAL FIBRILLATION; CARDIOTONIC AGENTS; DIGOXIN; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; OMEPRAZOLE; POISONING; TACHYCARDIA, PAROXYSMAL;

EID: 34147173864     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31802f34ea     Document Type: Article

References (5)

1. Andersson T. Pharmacokinetics, metabolism and interactions of acid pump inhibitors: focus on omeprazole, lansoprazole and pantoprazole. Clin Pharmacokinet 1996;31:9-28.
2. Oosterhuis B, Jonkman JH, Andersson T, et al. Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose. Br J Clin Pharmacol 1991;32:569-572.
3. Andersson T. Omeprazole drug interaction studies. Clin Pharmacokinet 1991;21:195-212.
4. Humphries TJ, Merritt GJ. Review article: drug interactions with agents used to treat acid-related diseases. Aliment Pharmacol Ther 1999;13 (Suppl 3):18-26.
5. Robinson M, Horn J. Clinical pharmacology of proton pump inhibitors: what the practicing physician needs to know. Drugs 2003;63:2739-2754.